カテゴリ： 世界, 医療/バイオ, QYResearch

一般用医薬品の世界市場2023年：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他

■ 英語タイトル：Global OTC Medicine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8219）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8219
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[一般用医薬品の世界市場2023年：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は一般用医薬品のグローバル市場について調査・分析し、世界の一般用医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他）、用途別セグメント分析（薬局、病院薬局、ネット通販、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euraditeなどが含まれています。一般用医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、一般用医薬品市場規模を算出する際に考慮しました。

・一般用医薬品市場の概要
- 一般用医薬品の種類別セグメント
- 世界の一般用医薬品市場規模：タイプ別分析（消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他）
- 一般用医薬品の用途別セグメント
- 世界の一般用医薬品市場規模：用途別分析（薬局、病院薬局、ネット通販、その他）
- 世界の一般用医薬品市場規模予測（2018年-2029年）

・一般用医薬品市場の成長トレンド
- 一般用医薬品の地域別市場規模（2018年-2029年）
- 一般用医薬品市場ダイナミクス
- 一般用医薬品の業界動向
- 一般用医薬品市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他
- 世界の一般用医薬品のタイプ別市場規模（2018年-2023年）
- 世界の一般用医薬品のタイプ別市場規模（2024年-2029年）

・用途別セグメント：薬局、病院薬局、ネット通販、その他
- 世界の一般用医薬品の用途別市場規模（2018年-2023年）
- 世界の一般用医薬品の用途別市場規模（2024年-2029年）

・一般用医薬品の地域別市場規模
- 北米の一般用医薬品市場規模（2018年-2029年）
- 米国の一般用医薬品市場規模（2018年-2029年）
- ヨーロッパの一般用医薬品市場規模（2018年-2029年）
- アジア太平洋の一般用医薬品市場規模（2018年-2029年）
- 中国の一般用医薬品市場規模（2018年-2029年）
- 日本の一般用医薬品市場規模（2018年-2029年）
- 韓国の一般用医薬品市場規模（2018年-2029年）
- インドの一般用医薬品市場規模（2018年-2029年）
- オーストラリアの一般用医薬品市場規模（2018年-2029年）
- 中南米の一般用医薬品市場規模（2018年-2029年）
- 中東・アフリカの一般用医薬品市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global OTC Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for OTC Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OTC Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for OTC Medicine in Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of OTC Medicine include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Medicine.
The OTC Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Segment by Type
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Segment by Application
Pharmacy
Hospital Pharmacy
Online Retailer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gastrointestinal Tract
1.2.3 Dermatology
1.2.4 Otolaryngology
1.2.5 Nutrition/Vitamins
1.2.6 Others
1.3 Market by Application
1.3.1 Global OTC Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Online Retailer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Medicine Market Perspective (2018-2029)
2.2 OTC Medicine Growth Trends by Region
2.2.1 Global OTC Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Medicine Historic Market Size by Region (2018-2023)
2.2.3 OTC Medicine Forecasted Market Size by Region (2024-2029)
2.3 OTC Medicine Market Dynamics
2.3.1 OTC Medicine Industry Trends
2.3.2 OTC Medicine Market Drivers
2.3.3 OTC Medicine Market Challenges
2.3.4 OTC Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Medicine Players by Revenue
3.1.1 Global Top OTC Medicine Players by Revenue (2018-2023)
3.1.2 Global OTC Medicine Revenue Market Share by Players (2018-2023)
3.2 Global OTC Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Medicine Revenue
3.4 Global OTC Medicine Market Concentration Ratio
3.4.1 Global OTC Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Medicine Revenue in 2022
3.5 OTC Medicine Key Players Head office and Area Served
3.6 Key Players OTC Medicine Product Solution and Service
3.7 Date of Enter into OTC Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Medicine Breakdown Data by Type
4.1 Global OTC Medicine Historic Market Size by Type (2018-2023)
4.2 Global OTC Medicine Forecasted Market Size by Type (2024-2029)
5 OTC Medicine Breakdown Data by Application
5.1 Global OTC Medicine Historic Market Size by Application (2018-2023)
5.2 Global OTC Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Medicine Market Size (2018-2029)
6.2 North America OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Medicine Market Size by Country (2018-2023)
6.4 North America OTC Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Medicine Market Size (2018-2029)
7.2 Europe OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Medicine Market Size by Country (2018-2023)
7.4 Europe OTC Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Medicine Market Size (2018-2029)
8.2 Asia-Pacific OTC Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Medicine Market Size (2018-2029)
9.2 Latin America OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Medicine Market Size by Country (2018-2023)
9.4 Latin America OTC Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Medicine Market Size (2018-2029)
10.2 Middle East & Africa OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Procter & Gamble
11.1.1 Procter & Gamble Company Detail
11.1.2 Procter & Gamble Business Overview
11.1.3 Procter & Gamble OTC Medicine Introduction
11.1.4 Procter & Gamble Revenue in OTC Medicine Business (2018-2023)
11.1.5 Procter & Gamble Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson OTC Medicine Introduction
11.2.4 Johnson & Johnson Revenue in OTC Medicine Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Detail
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc OTC Medicine Introduction
11.3.4 GlaxoSmithKline Plc Revenue in OTC Medicine Business (2018-2023)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories OTC Medicine Introduction
11.4.4 Abbott Laboratories Revenue in OTC Medicine Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Amway Corporation
11.5.1 Amway Corporation Company Detail
11.5.2 Amway Corporation Business Overview
11.5.3 Amway Corporation OTC Medicine Introduction
11.5.4 Amway Corporation Revenue in OTC Medicine Business (2018-2023)
11.5.5 Amway Corporation Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer OTC Medicine Introduction
11.6.4 Bayer Revenue in OTC Medicine Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Aktienge
11.7.1 Aktienge Company Detail
11.7.2 Aktienge Business Overview
11.7.3 Aktienge OTC Medicine Introduction
11.7.4 Aktienge Revenue in OTC Medicine Business (2018-2023)
11.7.5 Aktienge Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi OTC Medicine Introduction
11.8.4 Sanofi Revenue in OTC Medicine Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer OTC Medicine Introduction
11.9.4 Pfizer Revenue in OTC Medicine Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Reckitt Benckiser Group
11.10.1 Reckitt Benckiser Group Company Detail
11.10.2 Reckitt Benckiser Group Business Overview
11.10.3 Reckitt Benckiser Group OTC Medicine Introduction
11.10.4 Reckitt Benckiser Group Revenue in OTC Medicine Business (2018-2023)
11.10.5 Reckitt Benckiser Group Recent Development
11.11 Church & Dwight
11.11.1 Church & Dwight Company Detail
11.11.2 Church & Dwight Business Overview
11.11.3 Church & Dwight OTC Medicine Introduction
11.11.4 Church & Dwight Revenue in OTC Medicine Business (2018-2023)
11.11.5 Church & Dwight Recent Development
11.12 Bayer HealthCare
11.12.1 Bayer HealthCare Company Detail
11.12.2 Bayer HealthCare Business Overview
11.12.3 Bayer HealthCare OTC Medicine Introduction
11.12.4 Bayer HealthCare Revenue in OTC Medicine Business (2018-2023)
11.12.5 Bayer HealthCare Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca OTC Medicine Introduction
11.13.4 AstraZeneca Revenue in OTC Medicine Business (2018-2023)
11.13.5 AstraZeneca Recent Development
11.14 BioGaia
11.14.1 BioGaia Company Detail
11.14.2 BioGaia Business Overview
11.14.3 BioGaia OTC Medicine Introduction
11.14.4 BioGaia Revenue in OTC Medicine Business (2018-2023)
11.14.5 BioGaia Recent Development
11.15 Bristol Myers Squibb
11.15.1 Bristol Myers Squibb Company Detail
11.15.2 Bristol Myers Squibb Business Overview
11.15.3 Bristol Myers Squibb OTC Medicine Introduction
11.15.4 Bristol Myers Squibb Revenue in OTC Medicine Business (2018-2023)
11.15.5 Bristol Myers Squibb Recent Development
11.16 Chr. Hansen
11.16.1 Chr. Hansen Company Detail
11.16.2 Chr. Hansen Business Overview
11.16.3 Chr. Hansen OTC Medicine Introduction
11.16.4 Chr. Hansen Revenue in OTC Medicine Business (2018-2023)
11.16.5 Chr. Hansen Recent Development
11.17 Cipla
11.17.1 Cipla Company Detail
11.17.2 Cipla Business Overview
11.17.3 Cipla OTC Medicine Introduction
11.17.4 Cipla Revenue in OTC Medicine Business (2018-2023)
11.17.5 Cipla Recent Development
11.18 CoLucid
11.18.1 CoLucid Company Detail
11.18.2 CoLucid Business Overview
11.18.3 CoLucid OTC Medicine Introduction
11.18.4 CoLucid Revenue in OTC Medicine Business (2018-2023)
11.18.5 CoLucid Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Detail
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo OTC Medicine Introduction
11.19.4 Daiichi Sankyo Revenue in OTC Medicine Business (2018-2023)
11.19.5 Daiichi Sankyo Recent Development
11.20 Friggs
11.20.1 Friggs Company Detail
11.20.2 Friggs Business Overview
11.20.3 Friggs OTC Medicine Introduction
11.20.4 Friggs Revenue in OTC Medicine Business (2018-2023)
11.20.5 Friggs Recent Development
11.21 DSM
11.21.1 DSM Company Detail
11.21.2 DSM Business Overview
11.21.3 DSM OTC Medicine Introduction
11.21.4 DSM Revenue in OTC Medicine Business (2018-2023)
11.21.5 DSM Recent Development
11.22 Eisai
11.22.1 Eisai Company Detail
11.22.2 Eisai Business Overview
11.22.3 Eisai OTC Medicine Introduction
11.22.4 Eisai Revenue in OTC Medicine Business (2018-2023)
11.22.5 Eisai Recent Development
11.23 Eli Lilly
11.23.1 Eli Lilly Company Detail
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly OTC Medicine Introduction
11.23.4 Eli Lilly Revenue in OTC Medicine Business (2018-2023)
11.23.5 Eli Lilly Recent Development
11.24 Herbalife
11.24.1 Herbalife Company Detail
11.24.2 Herbalife Business Overview
11.24.3 Herbalife OTC Medicine Introduction
11.24.4 Herbalife Revenue in OTC Medicine Business (2018-2023)
11.24.5 Herbalife Recent Development
11.25 Euradite
11.25.1 Euradite Company Detail
11.25.2 Euradite Business Overview
11.25.3 Euradite OTC Medicine Introduction
11.25.4 Euradite Revenue in OTC Medicine Business (2018-2023)
11.25.5 Euradite Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global OTC Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Gastrointestinal Tract
Table 3. Key Players of Dermatology
Table 4. Key Players of Otolaryngology
Table 5. Key Players of Nutrition/Vitamins
Table 6. Key Players of Others
Table 7. Global OTC Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global OTC Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global OTC Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global OTC Medicine Market Share by Region (2018-2023)
Table 11. Global OTC Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global OTC Medicine Market Share by Region (2024-2029)
Table 13. OTC Medicine Market Trends
Table 14. OTC Medicine Market Drivers
Table 15. OTC Medicine Market Challenges
Table 16. OTC Medicine Market Restraints
Table 17. Global OTC Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global OTC Medicine Market Share by Players (2018-2023)
Table 19. Global Top OTC Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
Table 20. Ranking of Global Top OTC Medicine Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by OTC Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players OTC Medicine Product Solution and Service
Table 24. Date of Enter into OTC Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global OTC Medicine Revenue Market Share by Type (2018-2023)
Table 28. Global OTC Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global OTC Medicine Revenue Market Share by Type (2024-2029)
Table 30. Global OTC Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global OTC Medicine Revenue Market Share by Application (2018-2023)
Table 32. Global OTC Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global OTC Medicine Revenue Market Share by Application (2024-2029)
Table 34. North America OTC Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America OTC Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America OTC Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe OTC Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe OTC Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe OTC Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific OTC Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific OTC Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific OTC Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America OTC Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America OTC Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America OTC Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa OTC Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa OTC Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa OTC Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 49. Procter & Gamble Company Detail
Table 50. Procter & Gamble Business Overview
Table 51. Procter & Gamble OTC Medicine Product
Table 52. Procter & Gamble Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 53. Procter & Gamble Recent Development
Table 54. Johnson & Johnson Company Detail
Table 55. Johnson & Johnson Business Overview
Table 56. Johnson & Johnson OTC Medicine Product
Table 57. Johnson & Johnson Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 58. Johnson & Johnson Recent Development
Table 59. GlaxoSmithKline Plc Company Detail
Table 60. GlaxoSmithKline Plc Business Overview
Table 61. GlaxoSmithKline Plc OTC Medicine Product
Table 62. GlaxoSmithKline Plc Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 63. GlaxoSmithKline Plc Recent Development
Table 64. Abbott Laboratories Company Detail
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories OTC Medicine Product
Table 67. Abbott Laboratories Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Amway Corporation Company Detail
Table 70. Amway Corporation Business Overview
Table 71. Amway Corporation OTC Medicine Product
Table 72. Amway Corporation Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 73. Amway Corporation Recent Development
Table 74. Bayer Company Detail
Table 75. Bayer Business Overview
Table 76. Bayer OTC Medicine Product
Table 77. Bayer Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Aktienge Company Detail
Table 80. Aktienge Business Overview
Table 81. Aktienge OTC Medicine Product
Table 82. Aktienge Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 83. Aktienge Recent Development
Table 84. Sanofi Company Detail
Table 85. Sanofi Business Overview
Table 86. Sanofi OTC Medicine Product
Table 87. Sanofi Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Pfizer Company Detail
Table 90. Pfizer Business Overview
Table 91. Pfizer OTC Medicine Product
Table 92. Pfizer Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Reckitt Benckiser Group Company Detail
Table 95. Reckitt Benckiser Group Business Overview
Table 96. Reckitt Benckiser Group OTC Medicine Product
Table 97. Reckitt Benckiser Group Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 98. Reckitt Benckiser Group Recent Development
Table 99. Church & Dwight Company Detail
Table 100. Church & Dwight Business Overview
Table 101. Church & Dwight OTC Medicine Product
Table 102. Church & Dwight Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 103. Church & Dwight Recent Development
Table 104. Bayer HealthCare Company Detail
Table 105. Bayer HealthCare Business Overview
Table 106. Bayer HealthCare OTC Medicine Product
Table 107. Bayer HealthCare Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 108. Bayer HealthCare Recent Development
Table 109. AstraZeneca Company Detail
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca OTC Medicine Product
Table 112. AstraZeneca Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 113. AstraZeneca Recent Development
Table 114. BioGaia Company Detail
Table 115. BioGaia Business Overview
Table 116. BioGaia OTC Medicine Product
Table 117. BioGaia Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 118. BioGaia Recent Development
Table 119. Bristol Myers Squibb Company Detail
Table 120. Bristol Myers Squibb Business Overview
Table 121. Bristol Myers Squibb OTC Medicine Product
Table 122. Bristol Myers Squibb Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 123. Bristol Myers Squibb Recent Development
Table 124. Chr. Hansen Company Detail
Table 125. Chr. Hansen Business Overview
Table 126. Chr. Hansen OTC Medicine Product
Table 127. Chr. Hansen Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 128. Chr. Hansen Recent Development
Table 129. Cipla Company Detail
Table 130. Cipla Business Overview
Table 131. Cipla OTC Medicine Product
Table 132. Cipla Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 133. Cipla Recent Development
Table 134. CoLucid Company Detail
Table 135. CoLucid Business Overview
Table 136. CoLucid OTC Medicine Product
Table 137. CoLucid Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 138. CoLucid Recent Development
Table 139. Daiichi Sankyo Company Detail
Table 140. Daiichi Sankyo Business Overview
Table 141. Daiichi Sankyo OTC Medicine Product
Table 142. Daiichi Sankyo Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 143. Daiichi Sankyo Recent Development
Table 144. Friggs Company Detail
Table 145. Friggs Business Overview
Table 146. Friggs OTC Medicine Product
Table 147. Friggs Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 148. Friggs Recent Development
Table 149. DSM Company Detail
Table 150. DSM Business Overview
Table 151. DSM OTC Medicine Product
Table 152. DSM Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 153. DSM Recent Development
Table 154. Eisai Company Detail
Table 155. Eisai Business Overview
Table 156. Eisai OTC Medicine Product
Table 157. Eisai Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 158. Eisai Recent Development
Table 159. Eli Lilly Company Detail
Table 160. Eli Lilly Business Overview
Table 161. Eli Lilly OTC Medicine Product
Table 162. Eli Lilly Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 163. Eli Lilly Recent Development
Table 164. Herbalife Company Detail
Table 165. Herbalife Business Overview
Table 166. Herbalife OTC Medicine Product
Table 167. Herbalife Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 168. Herbalife Recent Development
Table 169. Euradite Company Detail
Table 170. Euradite Business Overview
Table 171. Euradite OTC Medicine Product
Table 172. Euradite Revenue in OTC Medicine Business (2018-2023) & (US$ Million)
Table 173. Euradite Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Medicine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global OTC Medicine Market Share by Type: 2022 VS 2029
Figure 3. Gastrointestinal Tract Features
Figure 4. Dermatology Features
Figure 5. Otolaryngology Features
Figure 6. Nutrition/Vitamins Features
Figure 7. Others Features
Figure 8. Global OTC Medicine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global OTC Medicine Market Share by Application: 2022 VS 2029
Figure 10. Pharmacy Case Studies
Figure 11. Hospital Pharmacy Case Studies
Figure 12. Online Retailer Case Studies
Figure 13. Others Case Studies
Figure 14. OTC Medicine Report Years Considered
Figure 15. Global OTC Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global OTC Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global OTC Medicine Market Share by Region: 2022 VS 2029
Figure 18. Global OTC Medicine Market Share by Players in 2022
Figure 19. Global Top OTC Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by OTC Medicine Revenue in 2022
Figure 21. North America OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America OTC Medicine Market Share by Country (2018-2029)
Figure 23. United States OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe OTC Medicine Market Share by Country (2018-2029)
Figure 27. Germany OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific OTC Medicine Market Share by Region (2018-2029)
Figure 35. China OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America OTC Medicine Market Share by Country (2018-2029)
Figure 43. Mexico OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa OTC Medicine Market Share by Country (2018-2029)
Figure 47. Turkey OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia OTC Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Procter & Gamble Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 51. GlaxoSmithKline Plc Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 52. Abbott Laboratories Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 53. Amway Corporation Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 54. Bayer Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 55. Aktienge Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 56. Sanofi Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 58. Reckitt Benckiser Group Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 59. Church & Dwight Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 60. Bayer HealthCare Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 61. AstraZeneca Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 62. BioGaia Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 63. Bristol Myers Squibb Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 64. Chr. Hansen Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 65. Cipla Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 66. CoLucid Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 67. Daiichi Sankyo Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 68. Friggs Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 69. DSM Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 70. Eisai Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 71. Eli Lilly Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 72. Herbalife Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 73. Euradite Revenue Growth Rate in OTC Medicine Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 動物飼料用微量元素の世界市場2023年：微量ミネラル、ビタミン
  • 免疫サポートビタミン&サプリメントのグローバル市場展望 2023年-2029年：ビタミン&ミネラルサプリメント、ハーブサプリメント、プロバイオティクスサプリメント、アミノ酸&タンパク質、オメガ3脂肪酸、その他
  • ビタミン＆栄養補助食品の世界市場 2022年-2026年
  • ダイエットサプリメントのグローバル市場展望 2023年-2029年：ビタミン&ミネラル、体重管理/スポーツ栄養補助食品、ハーブ植物エキス、プロバイオティクス、その他
  • 便秘用栄養補助食品のグローバル市場展望 2023年-2029年：繊維・特殊炭水化物、ビタミン、ミネラル、カロテノイド、オメガ-3脂肪酸、プレバイオティクス・プロバイオティクス、アミノ酸・タンパク質、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8219 )"一般用医薬品の世界市場2023年：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他" (英文：Global OTC Medicine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。